Mesoblast Ltd Files Quarterly Report
Ticker: MEOBF · Form: 6-K · Filed: Apr 30, 2025 · CIK: 1345099
| Field | Detail |
|---|---|
| Company | Mesoblast LTD (MEOBF) |
| Form Type | 6-K |
| Filed Date | Apr 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: quarterly-report, biotech
TL;DR
MESO filed its Q1 2025 update, check it for cash burn and progress.
AI Summary
On April 30, 2025, Mesoblast Limited filed a quarterly report (Appendix 4C) with the Australian Securities Exchange for the quarter ended March 31, 2025. The company is incorporated in Australia and its CEO is Silviu Itescu.
Why It Matters
This filing provides investors with an update on Mesoblast's financial and operational activities for the recent quarter, offering insights into the company's performance and strategic direction.
Risk Assessment
Risk Level: medium — As a biotechnology company, Mesoblast operates in a highly regulated and research-intensive industry with inherent risks related to clinical trials, drug development, and market approval.
Key Players & Entities
- Mesoblast Limited (company) — Registrant
- Silviu Itescu (person) — Chief Executive Officer and Executive Director
- April 30, 2025 (date) — Filing date
- March 31, 2025 (date) — Quarter end date
FAQ
What type of report did Mesoblast Limited file on April 30, 2025?
Mesoblast Limited filed a quarterly report (Appendix 4C) with the Australian Securities Exchange.
For which period is the quarterly report?
The quarterly report is for the quarter ended March 31, 2025.
What is Mesoblast Limited's jurisdiction of incorporation?
Mesoblast Limited's jurisdiction of incorporation is Australia.
Who is the Chief Executive Officer of Mesoblast Limited?
Silviu Itescu is the Chief Executive Officer and Executive Director of Mesoblast Limited.
Does Mesoblast Limited file annual reports under Form 20-F or Form 40-F?
Mesoblast Limited files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 30, 2025 by Silviu Itescu regarding MESOBLAST LTD (MEOBF).